Evidence map›Paper›PMID 41083628›Full record

ArticleImmunologic research2025

Characterisation and diagnostic model of monogenic lupus.

Mengyang Yang, Dan Lu, Yulu Li, Xiongbin Chen, Han Yang, Wenxiu Mo, Huawei Mao

Abstract read
PubMed Publisher
In one paragraph

Article in Immunologic research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mengyang YangDepartment of Immunology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Dan LuDepartment of Immunology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Yulu LiDepartment of Immunology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Xiongbin ChenDepartment of Immunology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Han YangDepartment of Immunology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Wenxiu MoDepartment of Immunology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Huawei MaoDepartment of Immunology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China. maohwei@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Standardised diagnostic criteria for monogenic lupus are lacking owing to its rarity, diverse phenotypes, and significant heterogeneity in pathogenesis, phenotypic characteristics, disease course, and outcomes. Further, no studies have analysed the characteristics of multiple pathological mechanisms of monogenic lupus. Therefore, we retrospectively summarised the clinical characteristics, genotypes, and treatment of 36 patients with monogenic lupus with 16 different gene mutations admitted to the Department of Immunology at Beijing Children's Hospital between June 2021 and July 2024. Children with classic lupus were randomly allocated to the control group. A univariate analysis was conducted on different pathogenic pathways to identify relevant significant risk factors. The least absolute shrinkage and selection operator and logistic regression were applied to construct multiple models. The discrimination and calibration abilities of these models were then evaluated, and the optimal diagnostic model for each pathway was proposed. We found that increased vigilance for monogenic lupus is necessary for male children with an onset age of < 8.46 years and a family history. Type-I-interferon disorders should be considered in patients with growth retardation, interstitial lung disease, intracranial calcifications, characteristic rashes, splenomegaly, and elevated liver enzymes. Monogenic lupus involving immune tolerance pathways should be considered in patients with repeated infections, lymphoproliferation, or elevated double-negative T-lymphocyte proportion. Monogenic lupus caused by another pathway should be considered in patients with abdominal symptoms, oral ulcers, and elevated C-reactive protein levels. Overall, our study proposes distinct diagnostic models based on various pathogenic pathways, aiding in early identification and diagnosis of monogenic lupus in children.

Indexed as

Lupus Erythematosus, SystemicAdolescentChildChild, PreschoolFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleMutationRetrospective StudiesRisk FactorsClinical characteristicsDiagnostic modelMonogenic lupusPathogenic pathways

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.